Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-12-12
1997-02-11
Datlow, Philip I.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540547, 540551, 540557, A61K 3155, C07D41304, C07D41704
Patent
active
056021216
ABSTRACT:
Described herein are D4 receptor-selective compounds of the general formula: ##STR1## wherein: A and B are independently selected, optionally substituted, saturated or unsaturated 5- or 6-membered, homo- or heterocyclic rings;
REFERENCES:
patent: 3458516 (1969-07-01), Howell et al.
patent: 3501483 (1970-03-01), Howell et al.
patent: 3539573 (1970-11-01), Schmutz
patent: 3546226 (1970-12-01), Schmutz
patent: 3751415 (1973-08-01), Schmutz
patent: 3758479 (1973-09-01), Schmutz
patent: 3908010 (1975-09-01), Schmutz
patent: 3983234 (1976-09-01), Sayers
patent: 4096261 (1978-06-01), Horrom
patent: 5354747 (1994-10-01), Hansen
The Merck Manual, 15th ed. (1987), Berkow, M.D. editor, pp. 2486-2487.
Gianai et al Synthesis, 1985, p. 550 "A new facile synthesis of 11-oxo-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepines".
Harris et al J Med Chem, 1982, 25:855 "Affinity of 10-(4-methylpiperazino)dibenz[b,f]oxepins for clozapine and spiroperidol binding sites in rat brain".
Klunder et al. J Med Chem, 1992, 35:1887 "Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase, tricyclic pyridobenzoxazepinones and dibenzoxazepinones".
de Paulis et al J Med Chem, 1981, 24(9):1021 "Synthesis of clozapine analogues and their affinity for clozapine and spiroperidol binding sites in rat brain".
Sindelar et al Coll. Czechoslov. Chem. Commun., 1977, 42:2231 "Noncataleptic potential neuroleptics: 2-nitro and 2-hydroxy derivatives of 10-(4-methylpiperzino)-10, 11-dihydrodibenzo[b,f]thiepin".
Allelix Biopharmaceuticals Inc.
Datlow Philip I.
LandOfFree
Alkyl-substituted compounds having dopamine receptor affinity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkyl-substituted compounds having dopamine receptor affinity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkyl-substituted compounds having dopamine receptor affinity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-342204